FindTrial
Sign In

The effects of thyrotropin-suppressing therapy on bone metabolism in the postoperative patients with thyroid cancer

The effects of thyrotropin-suppressing therapy on bone metabolism in the postoperative patients with thyroid cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000028977
Enrollment
Unknown
Registered
2020-01-10
Start date
2015-12-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Case series:TSH suppression therapy with thyroid supplement

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 100 Years

Inclusion criteria

Inclusion criteria: In the thyroid surgery department of our hospital, the patients who were hospitalized for papillary thyroid cancer, underwent total thyroidectomy, and needed long-term TSH suppression treatment

Exclusion criteria

Exclusion criteria: total thyroidectomy for other reasons; second operation; no measurement of bone mineral density and / or bone metabolism index before operation

Design outcomes

Primary

MeasureTime frame
Free triiodothyronine;Free tetraiodothyronine;Thyrotropin;DXA bone mineral density;parathyroid hormone;25 hydroxyvitamin D;Blood calcium;Bone alkaline phosphatase;type I collagen cross-linked C-telopeptide;albumin;alkaline phosphatase;Calcitonin;—

Countries

China

Contacts

Public ContactChun Yan LU

West China Hospital, Sichuan University

lcyan8306@163.com+86 18980601294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026